Two different subhuman primate models have been used to study HIV-1 pathogenesis and the development of a prophylactic vaccine. Chimpanzees: Following resolution of a primary HIV-1 infection initially induced by inoculating a mixture of three different virus strains, a chimpanzee was exposed to both immunostimulatory and immunosuppressive agents in an attempt to assess the contributions of different components of the immune system in suppressing circulating virus. The infusion of human leukocytes as an allogeneic stimulus induced the replication of one of the input virus strains that had not previously been isolated or detected by PCR. The administration of high-dose, 17 day courses of corticosteroids resulted in coordinate and transient increases of each of the three viruses present in the original inoculum and elevation of HIV-1 specific ELISA antibody levels. Steroids administered to a second chimpanzee, chronically infected with a single HIV-1 isolate, also induced elevations of cell-associated virus. To test whether the protective effects of attenuated SIV vaccines in macaques were applicable to the HIV-1/chimpanzee system, 2 groups of animals, previously infected with HIV-1(IIIB) or HIV-1(SF2), were each challenged with a heterologous clade B virus, HIV-1(DH12). In contrast to an HIV-1 naive chimpanzee that rapidly became infected following the inoculation of HIV-1(DH12), the two HIV-1(IIIB) previously infected chimpanzees resisted repeated and escalating inoculations of HIV-1(DH12), as monitored by virus isolation and PCR. The two previously HIV-1(SF2) infected animals became infected with HIV-1(DH12), but in contrast to the HIV-1 naive chimpanzee, no cell-free viral RNA was detected in the plasma by RT PCR and levels of PBMC-associated viral DNA were reduced 35 to 50-fold. Macaques: A series of SIV-HIV-1 chimeric viruses (SHIVs) were constructed and evaluated for their capacity to induce disease following inoculation into macaque monkeys. SHIVs containing the HIV-1 vpr, tat, rev, vpu, and env genes consistently induced rapid CD4 loss (within 2 to 3 weeks) following administration of virus prepared in PBMC from the inoculated animal (autologous virus); the SIV nef gene was required for reproducible disease induction. This system is being used to investigate critical events occurring during the first weeks of in vivo infection because of the very rapid and irreversible loss of CD4 cells observed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000415-12
Application #
2566767
Study Section
Special Emphasis Panel (LMM)
Project Start
Project End
Budget Start
Budget End
Support Year
12
Fiscal Year
1996
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Nishimura, Yoshiaki; Sadjadpour, Reza; Mattapallil, Joseph J et al. (2009) High frequencies of resting CD4+ T cells containing integrated viral DNA are found in rhesus macaques during acute lentivirus infections. Proc Natl Acad Sci U S A 106:8015-20
Nishimura, Yoshiaki; Igarashi, Tatsuhiko; Buckler-White, Alicia et al. (2007) Loss of naive cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaques. J Virol 81:893-902
Brown, Charles R; Czapiga, Meggan; Kabat, Juraj et al. (2007) Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDS. J Virol 81:5594-606
Igarashi, Tatsuhiko; Iyengar, Ranjini; Byrum, Russel A et al. (2007) Human immunodeficiency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pig-tailed macaques. J Virol 81:11549-52
Mattapallil, Joseph J; Douek, Daniel C; Hill, Brenna et al. (2005) Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434:1093-7
Nishimura, Yoshiaki; Brown, Charles R; Mattapallil, Joseph J et al. (2005) Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques. Proc Natl Acad Sci U S A 102:8000-5
Nishimura, Yoshiaki; Igarashi, Tatsuhiko; Donau, Olivia K et al. (2004) Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses. Proc Natl Acad Sci U S A 101:12324-9
Igarashi, Tatsuhiko; Imamichi, Hiromi; Brown, Charles R et al. (2003) The emergence and characterization of macrophage-tropic SIV/HIV chimeric viruses (SHIVs) present in CD4+ T cell-depleted rhesus monkeys. J Leukoc Biol 74:772-80
Lafont, Bernard A P; Buckler-White, Alicia; Plishka, Ron et al. (2003) Characterization of pig-tailed macaque classical MHC class I genes: implications for MHC evolution and antigen presentation in macaques. J Immunol 171:875-85
Igarashi, Tatsuhiko; Donau, Olivia K; Imamichi, Hiromi et al. (2003) Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages. J Virol 77:13042-52

Showing the most recent 10 out of 19 publications